tulobuterol has been researched along with albuterol in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (33.33) | 18.7374 |
1990's | 3 (10.00) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
Bultsma, T; IJzerman, AP; Timmerman, H | 1 |
Aué, GH; Bultsma, T; IJzerman, AP; Linschoten, MR; Timmerman, H | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Raaijmakers, JA; Terpstra, GK | 1 |
Aldons, PM | 1 |
Germouty, J | 1 |
Jorde, W; Schata, M | 1 |
Reeh, PW; Schaffler, K | 1 |
Matthys, H; Schulte-Mönting, J; Weil, R; Würtemberger, G | 1 |
Azanza, JR; Dal-Re, R; Rivero, A; Sanchez, J | 1 |
Patel, KR | 2 |
Henion, J; Sheppard, RL; Wachs, T | 1 |
Ebihara, M; Nakagawa, Y; Nakamura, H; Ojima, F; Shoji, T; Tomike, H | 1 |
Stalcup, AM; Vela, J; Yanes, EG | 1 |
Tamura, G | 1 |
Agematsu, K; Baba, A; Kobayashi, N; Matsuzaki, S; Nakata, S; Yamazaki, T; Yasui, K | 1 |
Aizawa, H; Fukuchi, Y; Hirata, K; Ichinose, M; Kubo, K; Nagai, A; Nishimura, M; Seyama, K | 1 |
Fujimoto, K; Komatsu, Y; Kubo, K; Urushihata, K; Yasuo, M | 1 |
Kato, K; Kimura, T; Kondoh, Y; Kume, H; Nishiyama, O; Shimokata, K; Taniguchi, H | 1 |
Kita, H; Kobayashi, Y; Kudou, M; Yasuba, H | 1 |
Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Ueshima, K; Yamagata, T; Yanagisawa, S | 1 |
Jia, X; Meng, J; Qu, J; Shao, B | 1 |
Higashihara, K; Mochizuki, H; Nanjo, Y; Noguchi, T; Sugawara, T; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
Mochizuki, H; Nanjo, Y; Takahashi, H | 1 |
Bao, YX; Lin, Q; Liu, QH | 1 |
Bian, L; Li, Q; Li, Z; Wang, J; Yang, L; Zhang, Y; Zhao, X; Zheng, J; Zheng, YY | 1 |
Di, X; Guo, X; Jiang, Z; Liu, Y; Lun, J; Zhou, L | 1 |
1 review(s) available for tulobuterol and albuterol
Article | Year |
---|---|
[Long-acting beta 2-stimulants].
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Terbutaline; Time Factors | 2001 |
16 trial(s) available for tulobuterol and albuterol
Article | Year |
---|---|
Can a new beta 2-agonist reduce the mortality of asthma?
Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Airway Resistance; Albuterol; Asthma; Australia; Bronchodilator Agents; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Terbutaline | 1990 |
Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Drug Tolerance; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Terbutaline | 1986 |
[Beta-2 specificity of bronchially active sympathomimetics using capillary laser Doppler sonography exemplified by tulobuterol].
Topics: Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Double-Blind Method; Female; Humans; Male; Respiratory Hypersensitivity; Rheology; Terbutaline | 1987 |
Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Electromyography; Heart Rate; Humans; Isometric Contraction; Male; Muscle Contraction; Muscle Relaxation; Random Allocation; Terbutaline; Tremor | 1987 |
[Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Female; Fenoterol; Forced Expiratory Flow Rates; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Terbutaline | 1988 |
Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients.
Topics: Adult; Albuterol; Asthma; Drug Evaluation; Fenoterol; Humans; Middle Aged; Random Allocation; Respiratory Function Tests; Terbutaline | 1988 |
Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.
Topics: Adult; Albuterol; Asthma; Asthma, Exercise-Induced; Blood Pressure; Bronchodilator Agents; Clinical Trials as Topic; Double-Blind Method; Forced Expiratory Volume; Humans; Middle Aged; Pulse; Terbutaline; Time Factors; Vital Capacity | 1986 |
Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Male; Middle Aged; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Terbutaline; Time Factors | 2005 |
Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2006 |
Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Topics: Administration, Cutaneous; Aged; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Middle Aged; Random Allocation; Salmeterol Xinafoate; Terbutaline | 2006 |
Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Fluticasone; Forced Expiratory Volume; Humans; Middle Aged; Patient Compliance; Patient Satisfaction; Salmeterol Xinafoate; Terbutaline | 2007 |
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Technology, Pharmaceutical; Terbutaline | 2008 |
Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2009 |
β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Drug Tolerance; Female; Haplotypes; Humans; Male; Pharmacogenetics; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Time Factors; Transdermal Patch; Treatment Outcome; Walking | 2012 |
Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Age Factors; Aged; Aged, 80 and over; Albuterol; Cross-Over Studies; Exercise Tolerance; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inspiratory Capacity; Male; Maximal Midexpiratory Flow Rate; Medication Adherence; Mental Status Schedule; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Quality of Life; Residual Volume; Salmeterol Xinafoate; Spirometry; Terbutaline; Total Lung Capacity; Treatment Outcome; Vital Capacity; Walking | 2013 |
[Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
Topics: Acute Disease; Administration, Oral; Adrenergic beta-2 Receptor Agonists; Albuterol; Asthma; Female; Humans; Terbutaline | 2013 |
13 other study(ies) available for tulobuterol and albuterol
Article | Year |
---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Quantitative evaluation of the beta 2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines.
Topics: Adrenergic beta-Agonists; Animals; Cattle; Cyclic AMP; Ethanolamines; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Receptors, Adrenergic, beta; Regression Analysis; Structure-Activity Relationship | 1986 |
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Dihydroalprenolol; Ethanolamines; Guanylyl Imidodiphosphate; Hydrogen-Ion Concentration; Muscles; Propanolamines; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1985 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Beta-agonistic properties of tulobuterol, a new beta-sympathicomimetic drug, and its effects on pulmonary beta-adrenoceptor characteristics.
Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Animals; Binding, Competitive; Bronchodilator Agents; Dihydroalprenolol; Humans; Long-Term Care; Lung; Male; Rats; Receptors, Adrenergic, beta; Terbutaline | 1990 |
Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Forced Expiratory Volume; Hemodynamics; Humans; Middle Aged; Peak Expiratory Flow Rate; Terbutaline; Time Factors; Vital Capacity | 1985 |
Design and applications of a self-aligning liquid junction-electrospray interface for capillary electrophoresis-mass spectrometry.
Topics: Adrenergic beta-Agonists; Albuterol; Clenbuterol; Electrophoresis, Capillary; Ephedrine; Fenoterol; Isoproterenol; Mass Spectrometry; Metaproterenol; Terbutaline | 1996 |
Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Child; Drug Information Services; Drug Utilization; Hospitals, University; Humans; Japan; Middle Aged; Nebulizers and Vaporizers; Procaterol; Retrospective Studies; Severity of Illness Index; Terbutaline | 2001 |
Quantitative determination of clenbuterol, salbutamol and tulobuterol enantiomers by capillary electrophoresis.
Topics: Albuterol; beta-Cyclodextrins; Bronchodilator Agents; Buffers; Clenbuterol; Cyclodextrins; Electrophoresis, Capillary; Indicators and Reagents; Molecular Structure; Reproducibility of Results; Stereoisomerism; Terbutaline | 2001 |
Differential effects of short-acting beta2-agonists on human granulocyte functions.
Topics: Adrenergic beta-Agonists; Albuterol; Cell Degranulation; Depression, Chemical; Eosinophils; Granulocytes; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Procaterol; Superoxides; Terbutaline | 2006 |
[Simultaneous determination of nine beta2-agonists residues in urines by ultra performance liquid chromatography-electrospray tandem mass spectrometry].
Topics: Adrenergic beta-Agonists; Albuterol; Humans; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Terbutaline | 2007 |
Comparison of zonal elution and nonlinear chromatography in determination of the interaction between seven drugs and immobilised β(2)-adrenoceptor.
Topics: Albuterol; Alcohols; Binding Sites; Chemistry Techniques, Analytical; Chromatography, Affinity; Clenbuterol; Drug Interactions; Fluconazole; Radioligand Assay; Receptors, Adrenergic, beta-2; Terbutaline | 2015 |
In situ immobilization of sulfated-β-cyclodextrin as stationary phase for capillary electrochromatography enantioseparation.
Topics: Albuterol; beta-Cyclodextrins; Brompheniramine; Capillary Electrochromatography; Chlorpheniramine; Clenbuterol; Isoproterenol; Particle Size; Pheniramine; Surface Properties; Terbutaline; Tolterodine Tartrate | 2019 |